The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)



Gene Review

ECM1  -  extracellular matrix protein 1

Homo sapiens

Synonyms: Extracellular matrix protein 1, Secretory component p85
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of ECM1


Psychiatry related information on ECM1


High impact information on ECM1

  • In addition, PTX3 is essential in female fertility because it acts as a nodal point for the assembly of the cumulus oophorus hyaluronan-rich extracellular matrix [12].
  • Within these sites, integrins facilitate cell movement via interactions with the extracellular matrix, and promote and stabilize antigen-specific interactions between T lymphocytes and APCs that are critical for initiating T cell-activation events [13].
  • Critical determinants of the in vivo activities of chemokines in the immune system include their presentation by endothelial cells and extracellular matrix molecules, as well as their cellular uptake via "silent" chemokine receptors (interceptors) leading either to their transcytosis or to degradation [14].
  • Finally, IL-13 was revealed as a potent mediator of tissue fibrosis in both schistosomiasis and asthma, which indicates that it is a key regulator of the extracellular matrix [15].
  • Cycles of avidity change are also observed for other T lymphocyte integrins which bind to extracellular matrix components [16].

Chemical compound and disease context of ECM1


Biological context of ECM1

  • Using a candidate gene approach (comparison of control versus LP gene expression in cultured fibroblasts) and subsequent direct sequencing of genomic DNA, we identified six different homozygous loss-of-function mutations in the extracellular matrix protein 1 gene (ECM1) [22].
  • Although the precise function of ECM1 is not known, our findings provide the first clinical indication of its relevance to skin adhesion, epidermal differentiation, wound healing, scarring, angiogenesis/angiopathy and basement membrane physiology, as well as defining the molecular basis of this inherited disorder [22].
  • Taken with the previously documented mutations in ECM1, this study supports the view that exons 6 and 7 are the most common sites for ECM1 mutations in lipoid proteinosis [23].
  • The mutation 507delT occurred in two unrelated subjects on different ECM1 haplotypes and may therefore represent a recurrent mutation in lipoid proteinosis [23].
  • The ECM1 gene maps at chromosome 1q21 outside the epidermal differentiation complex region [24].

Anatomical context of ECM1


Associations of ECM1 with chemical compounds


Physical interactions of ECM1


Enzymatic interactions of ECM1


Co-localisations of ECM1


Regulatory relationships of ECM1


Other interactions of ECM1

  • The increased expression of TIMP-1 may reflect a specific temporal inhibition of collagenolysis and thereby a time-dependent regulation of ECM breakdown in areas surrounding the apex of the follicle [50].
  • Matrix metalloproteinases (MMPs) and urokinase plasminogen activation (uPA) system are shown to be involved in tumor invasion as they help in degradation of extracellular matrix (ECM) proteins and thus assist in the movement of cells [51].
  • Taken together, this study discusses MMP-9 inhibition potential of CCOS and their involvement to demote degradation and cellular invasion of extracellular matrix (ECM) and basement membrane [52].
  • These results suggest that PTEN inhibits glioma cell invasion in two ways: suppressing proteolysis of the extracellular matrix by MMPs and modulating the migratory activity of glioma cells to a less motile nature by inactivating two Rho-family GTP-binding proteins, Rac and Cdc42 [53].
  • In squamous cell carcinomas of the head and neck (SCCHN), hypoxia is considered a pivotal physiological modulator for malignant progression, whereby the plasminogen activation system is involved in overlapping functions such as the shaping of the extracellular matrix, cell proliferation and signal transduction [54].

Analytical, diagnostic and therapeutic context of ECM1


  1. Differential Diagnosis of Azoospermia with Proteomic Biomarkers ECM1 and TEX101 Quantified in Seminal Plasma. Drabovich, A.P., Dimitromanolakis, A., Saraon, P., Soosaipillai, A., Batruch, I., Mullen, B., Jarvi, K., Diamandis, E.P. Sci. Transl. Med. (2013) [Pubmed]
  2. Verification of male infertility biomarkers in seminal plasma by multiplex selected reaction monitoring assay. Drabovich, A.P., Jarvi, K., Diamandis, E.P. Mol. Cell. Proteomics. (2011) [Pubmed]
  3. Extracellular matrix protein 1 (ECM1) is over-expressed in malignant epithelial tumors. Wang, L., Yu, J., Ni, J., Xu, X.M., Wang, J., Ning, H., Pei, X.F., Chen, J., Yang, S., Underhill, C.B., Liu, L., Liekens, J., Merregaert, J., Zhang, L. Cancer Lett. (2003) [Pubmed]
  4. Extracellular matrix turnover and disease severity in Anderson-Fabry disease. Shah, J.S., Hughes, D.A., Tayebjee, M.H., MacFadyen, R.J., Mehta, A.B., Elliott, P.M. Journal of inherited metabolic disease (2007) [Pubmed]
  5. Biglycan is overexpressed in pancreatic cancer and induces G1-arrest in pancreatic cancer cell lines. Weber, C.K., Sommer, G., Michl, P., Fensterer, H., Weimer, M., Gansauge, F., Leder, G., Adler, G., Gress, T.M. Gastroenterology (2001) [Pubmed]
  6. Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome. Bergamaschi, A., Tagliabue, E., Sørlie, T., Naume, B., Triulzi, T., Orlandi, R., Russnes, H.G., Nesland, J.M., Tammi, R., Auvinen, P., Kosma, V.M., Ménard, S., Børresen-Dale, A.L. J. Pathol. (2008) [Pubmed]
  7. The angiopathy of subcortical arteriosclerotic encephalopathy (Binswanger's disease): immunohistochemical studies using markers for components of extracellular matrix, smooth muscle actin and endothelial cells. Zhang, W.W., Olsson, Y. Acta Neuropathol. (1997) [Pubmed]
  8. Role of extracellular matrix in adaptation of tendon and skeletal muscle to mechanical loading. Kjaer, M. Physiol. Rev. (2004) [Pubmed]
  9. Remarkable roles of proteolysis on and beyond the cell surface. Blobel, C.P. Curr. Opin. Cell Biol. (2000) [Pubmed]
  10. Cell adhesion molecules, signal transduction and cell growth. Aplin, A.E., Howe, A.K., Juliano, R.L. Curr. Opin. Cell Biol. (1999) [Pubmed]
  11. The superfamily of proteins with von Willebrand factor type A-like domains: one theme common to components of extracellular matrix, hemostasis, cellular adhesion, and defense mechanisms. Colombatti, A., Bonaldo, P. Blood (1991) [Pubmed]
  12. Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility. Garlanda, C., Bottazzi, B., Bastone, A., Mantovani, A. Annu. Rev. Immunol. (2005) [Pubmed]
  13. Integrins and T cell-mediated immunity. Pribila, J.T., Quale, A.C., Mueller, K.L., Shimizu, Y. Annu. Rev. Immunol. (2004) [Pubmed]
  14. Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. Rot, A., von Andrian, U.H. Annu. Rev. Immunol. (2004) [Pubmed]
  15. IL-13 effector functions. Wynn, T.A. Annu. Rev. Immunol. (2003) [Pubmed]
  16. Role of lymphocyte adhesion receptors in transient interactions and cell locomotion. Dustin, M.L., Springer, T.A. Annu. Rev. Immunol. (1991) [Pubmed]
  17. German cockroach proteases regulate matrix metalloproteinase-9 in human bronchial epithelial cells. Page, K., Hughes, V.S., Bennett, G.W., Wong, H.R. Allergy (2006) [Pubmed]
  18. Protease nexin-1 expression is altered in human breast cancer. Candia, B.J., Hines, W.C., Heaphy, C.M., Griffith, J.K., Orlando, R.A. Cancer Cell Int. (2006) [Pubmed]
  19. Development of antigen-specific ELISA for circulating autoantibodies to extracellular matrix protein 1 in lichen sclerosus. Oyama, N., Chan, I., Neill, S.M., South, A.P., Wojnarowska, F., Kawakami, Y., D'Cruz, D., Mepani, K., Hughes, G.J., Bhogal, B.S., Kaneko, F., Black, M.M., McGrath, J.A. J. Clin. Invest. (2004) [Pubmed]
  20. Relationship between matrix metalloproteinases MMP-2, MMP-9, tissue inhibitor of matrix metalloproteinases-1 and IL-5, IL-8 in nasal polyps. Chen, Y.S., Langhammer, T., Westhofen, M., Lorenzen, J. Allergy (2007) [Pubmed]
  21. Immunohistochemical expression of cathepsin D in correlation with extracellular matrix component, steroid receptor status and proliferative indices in breast cancer. Ioachim, E., Kamina, S., Kontostolis, M., Agnantis, N.J. Virchows Arch. (1997) [Pubmed]
  22. Lipoid proteinosis maps to 1q21 and is caused by mutations in the extracellular matrix protein 1 gene (ECM1). Hamada, T., McLean, W.H., Ramsay, M., Ashton, G.H., Nanda, A., Jenkins, T., Edelstein, I., South, A.P., Bleck, O., Wessagowit, V., Mallipeddi, R., Orchard, G.E., Wan, H., Dopping-Hepenstal, P.J., Mellerio, J.E., Whittock, N.V., Munro, C.S., van Steensel, M.A., Steijlen, P.M., Ni, J., Zhang, L., Hashimoto, T., Eady, R.A., McGrath, J.A. Hum. Mol. Genet. (2002) [Pubmed]
  23. Extracellular matrix protein 1 gene (ECM1) mutations in lipoid proteinosis and genotype-phenotype correlation. Hamada, T., Wessagowit, V., South, A.P., Ashton, G.H., Chan, I., Oyama, N., Siriwattana, A., Jewhasuchin, P., Charuwichitratana, S., Thappa, D.M., Jeevankumar, B., Lenane, P., Krafchik, B., Kulthanan, K., Shimizu, H., Kaya, T.I., Erdal, M.E., Paradisi, M., Paller, A.S., Seishima, M., Hashimoto, T., McGrath, J.A. J. Invest. Dermatol. (2003) [Pubmed]
  24. The human extracellular matrix gene 1 (ECM1): genomic structure, cDNA cloning, expression pattern, and chromosomal localization. Smits, P., Ni, J., Feng, P., Wauters, J., Van Hul, W., Boutaibi, M.E., Dillon, P.J., Merregaert, J. Genomics (1997) [Pubmed]
  25. Distribution of hyaluronan during extracellular matrix remodeling in human restenotic arteries and balloon-injured rat carotid arteries. Riessen, R., Wight, T.N., Pastore, C., Henley, C., Isner, J.M. Circulation (1996) [Pubmed]
  26. Oncostatin M induces angiogenesis and cartilage degradation in rheumatoid arthritis synovial tissue and human cartilage cocultures. Fearon, U., Mullan, R., Markham, T., Connolly, M., Sullivan, S., Poole, A.R., Fitzgerald, O., Bresnihan, B., Veale, D.J. Arthritis Rheum. (2006) [Pubmed]
  27. Differentiation-dependent alternative splicing and expression of the extracellular matrix protein 1 gene in human keratinocytes. Smits, P., Poumay, Y., Karperien, M., Tylzanowski, P., Wauters, J., Huylebroeck, D., Ponec, M., Merregaert, J. J. Invest. Dermatol. (2000) [Pubmed]
  28. The relationship of VEGF and PGE2 expression to extracellular matrix remodelling of the tenosynovium in the carpal tunnel syndrome. Hirata, H., Nagakura, T., Tsujii, M., Morita, A., Fujisawa, K., Uchida, A. J. Pathol. (2004) [Pubmed]
  29. Effects of rhDecorin on TGF-beta1 induced human hepatic stellate cells LX-2 activation. Shi, Y.F., Zhang, Q., Cheung, P.Y., Shi, L., Fong, C.C., Zhang, Y., Tzang, C.H., Chan, B.P., Fong, W.F., Chun, J., Kung, H.F., Yang, M. Biochim. Biophys. Acta (2006) [Pubmed]
  30. Coordinate signaling by integrins and receptor tyrosine kinases in the regulation of G1 phase cell-cycle progression. Assoian, R.K., Schwartz, M.A. Curr. Opin. Genet. Dev. (2001) [Pubmed]
  31. Engagement of alphavbeta3 integrin regulates proliferation and apoptosis of hepatic stellate cells. Zhou, X., Murphy, F.R., Gehdu, N., Zhang, J., Iredale, J.P., Benyon, R.C. J. Biol. Chem. (2004) [Pubmed]
  32. Beta-1-integrin expression in adult acute lymphoblastic leukemia: possible relationship with the stem cell antigen CD34. Cacciola, R.R., Stagno, F., Impera, S., Assisi, A.R., Cacciola, E., Guglielmo, P. Acta Haematol. (1997) [Pubmed]
  33. TNF-alpha induction of CD44-mediated leukocyte adhesion by sulfation. Maiti, A., Maki, G., Johnson, P. Science (1998) [Pubmed]
  34. Association of the small latent transforming growth factor-beta with an eight cysteine repeat of its binding protein LTBP-1. Saharinen, J., Taipale, J., Keski-Oja, J. EMBO J. (1996) [Pubmed]
  35. VEGF145, a secreted vascular endothelial growth factor isoform that binds to extracellular matrix. Poltorak, Z., Cohen, T., Sivan, R., Kandelis, Y., Spira, G., Vlodavsky, I., Keshet, E., Neufeld, G. J. Biol. Chem. (1997) [Pubmed]
  36. Estradiol and fibulin-1 inhibit motility of human ovarian- and breast-cancer cells induced by fibronectin. Hayashido, Y., Lucas, A., Rougeot, C., Godyna, S., Argraves, W.S., Rochefort, H. Int. J. Cancer (1998) [Pubmed]
  37. Tissue inhibitor of metalloproteinase (TIMP)-2 acts synergistically with synthetic matrix metalloproteinase (MMP) inhibitors but not with TIMP-4 to enhance the (Membrane type 1)-MMP-dependent activation of pro-MMP-2. Toth, M., Bernardo, M.M., Gervasi, D.C., Soloway, P.D., Wang, Z., Bigg, H.F., Overall, C.M., DeClerck, Y.A., Tschesche, H., Cher, M.L., Brown, S., Mobashery, S., Fridman, R. J. Biol. Chem. (2000) [Pubmed]
  38. A scaffold protein in the c-Jun N-terminal kinase signaling pathway is associated with focal adhesion kinase and tyrosine-phosphorylated. Takino, T., Yoshioka, K., Miyamori, H., Yamada, K.M., Sato, H. Oncogene (2002) [Pubmed]
  39. Paired basic/Furin-like proprotein convertase cleavage of Pro-BMP-1 in the trans-Golgi network. Leighton, M., Kadler, K.E. J. Biol. Chem. (2003) [Pubmed]
  40. ADAM 12 cleaves extracellular matrix proteins and correlates with cancer status and stage. Roy, R., Wewer, U.M., Zurakowski, D., Pories, S.E., Moses, M.A. J. Biol. Chem. (2004) [Pubmed]
  41. Identification and characterization of human endometase (Matrix metalloproteinase-26) from endometrial tumor. Park, H.I., Ni, J., Gerkema, F.E., Liu, D., Belozerov, V.E., Sang, Q.X. J. Biol. Chem. (2000) [Pubmed]
  42. Tenascin-C splice variant adhesive/anti-adhesive effects on chondrosarcoma cell attachment to fibronectin. Ghert, M.A., Qi, W.N., Erickson, H.P., Block, J.A., Scully, S.P. Cell Struct. Funct. (2001) [Pubmed]
  43. The receptor for urokinase-type plasminogen activator regulates fibronectin matrix assembly in human skin fibroblasts. Monaghan, E., Gueorguiev, V., Wilkins-Port, C., McKeown-Longo, P.J. J. Biol. Chem. (2004) [Pubmed]
  44. Adhesive properties of isolated chick osteocytes in vitro. Aarden, E.M., Nijweide, P.J., van der Plas, A., Alblas, M.J., Mackie, E.J., Horton, M.A., Helfrich, M.H. Bone (1996) [Pubmed]
  45. A coding polymorphism in matrix metalloproteinase 9 reduces risk of scarring sequelae of ocular Chlamydia trachomatis infection. Natividad, A., Cooke, G., Holland, M.J., Burton, M.J., Joof, H.M., Rockett, K., Kwiatkowski, D.P., Mabey, D.C., Bailey, R.L. BMC Med. Genet. (2006) [Pubmed]
  46. Connective tissue growth factor (CTGF/CCN2) is a downstream mediator for TGF-beta1-induced extracellular matrix production in osteoblasts. Arnott, J.A., Nuglozeh, E., Rico, M.C., Arango-Hisijara, I., Odgren, P.R., Safadi, F.F., Popoff, S.N. J. Cell. Physiol. (2007) [Pubmed]
  47. Integrins and cell proliferation: regulation of cyclin-dependent kinases via cytoplasmic signaling pathways. Schwartz, M.A., Assoian, R.K. J. Cell. Sci. (2001) [Pubmed]
  48. Group A Streptococcus tissue invasion by CD44-mediated cell signalling. Cywes, C., Wessels, M.R. Nature (2001) [Pubmed]
  49. ICAM-3 regulates lymphocyte morphology and integrin-mediated T cell interaction with endothelial cell and extracellular matrix ligands. Campanero, M.R., Sánchez-Mateos, P., del Pozo, M.A., Sánchez-Madrid, F. J. Cell Biol. (1994) [Pubmed]
  50. Gelatinases and their tissue inhibitors during human ovulation: increased expression of tissue inhibitor of matrix metalloproteinase-1. Lind, A.K., Dahm-K??hler, P., Weijdeg??rd, B., Sundfeldt And, K., Br??nnstr??m, M. Mol. Hum. Reprod. (2006) [Pubmed]
  51. Inhibition of matrix degrading enzymes and invasion in human glioblastoma (U87MG) Cells by isoflavones. Puli, S., Lai, J.C., Bhushan, A. J. Neurooncol. (2006) [Pubmed]
  52. Carboxylated chitooligosaccharides (CCOS) inhibit MMP-9 expression in human fibrosarcoma cells via down-regulation of AP-1. Rajapakse, N., Kim, M.M., Mendis, E., Huang, R., Kim, S.K. Biochim. Biophys. Acta (2006) [Pubmed]
  53. PTEN gene transfer suppresses the invasive potential of human malignant gliomas by regulating cell invasion-related molecules. Furukawa, K., Kumon, Y., Harada, H., Kohno, S., Nagato, S., Teraoka, M., Fujiwara, S., Nakagawa, K., Hamada, K., Ohnishi, T. Int. J. Oncol. (2006) [Pubmed]
  54. Effects of hypoxia and reoxygenation on the expression levels of the urokinase-type plasminogen activator, its inhibitor plasminogen activator inhibitor type-1 and the urokinase-type plasminogen activator receptor in human head and neck tumour cells. Sprague, L.D., Tomaso, H., Mengele, K., Schilling, D., Bayer, C., Stadler, P., Schmitt, M., Molls, M. Oncol. Rep. (2007) [Pubmed]
  55. Characterization of the human extracellular matrix protein 1 gene on chromosome 1q21. Johnson, M.R., Wilkin, D.J., Vos, H.L., Ortiz de Luna, R.I., Dehejia, A.M., Polymeropoulos, M.H., Francomano, C.A. Matrix Biol. (1997) [Pubmed]
  56. Analysis of human skeletal muscle after 48 h immobilization reveals alterations in mRNA and protein for extracellular matrix components. Urso, M.L., Scrimgeour, A.G., Chen, Y.W., Thompson, P.D., Clarkson, P.M. J. Appl. Physiol. (2006) [Pubmed]
  57. Extracellular matrix protein 1 (ECM1) has angiogenic properties and is expressed by breast tumor cells. Han, Z., Ni, J., Smits, P., Underhill, C.B., Xie, B., Chen, Y., Liu, N., Tylzanowski, P., Parmelee, D., Feng, P., Ding, I., Gao, F., Gentz, R., Huylebroeck, D., Merregaert, J., Zhang, L. FASEB J. (2001) [Pubmed]
WikiGenes - Universities